Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis

Arthritis Research and Therapy

Volumn 8, Issue 1, 2005, Pages

  Jongbloed, Sarah L ^a   Lebre, M Cristina ^b   Fraser, Alasdair R ^a   Gracie, J Alastair ^a   Sturrock, Roger D ^a   Tak, Paul P ^b   McInnes, Iain B ^a  

^a Division of Immunology Infection and Inflammation   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350513152     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1864     Document Type: Article

References (77)

1. Ferrari-Lacraz S, Zanelli E, Neuberg M, Donskoy E, Kim YS, Zheng XX, Hancock WW, Maslinski W, Li XC, Strom TB, Moll T: Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. J Immunol 2004, 173:5818-5826.
2. Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, Kishimoto T: Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2004, 50:1761-1769.
3. Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY: Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: A role for IL-15 in development of antigen-induced immunopathology. J Immunol 1998, 160:5654-5660.
4. Wendling D, Racadot E, Wijdenes J: Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 1993, 20:259-262.
5. Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S, Russell A, Dougados M, Emery P, Nuamah IF, et al.: Treatment of rheumatoid arthritis by selective inhibition of T cell activation with fusion protein CTLA4Ig. N Engl J Med 2003, 349:1907-1915.
6. Protheroe A, Edwards JC, Simmons A, Maclennan K, Selby P: Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma. Rheumatology (Oxford) 1999, 38 1150-1152.
7. Edwards JC, Cambridge G: Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 2001, 40:205-211.
8. Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS, Menter A, Lowe NJ, Krueger G, Brown MJ, et al.: CTLA4Ig-mediated blockade of T cell costimulation in patients with psoriasis vulgaris. J Clin Invest 1999, 103:1243-1252.
9. Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG: Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 2000, 192:681-694.
10. Gottlieb A, Krueger JG, Bright R, Ling M, Lebwohl M, Kang S, Feldman S, Spellman M, Wittkowski K, Ochs HD, et al.: Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 2000, 42:428-435.
11. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Menard HA, et al.: Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000, 2:236-243.
12. Ronnelid J, Lysholm J, Engstrom-Laurent A, Klareskog L, Heyman B: Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum 1994, 37:1023-1029.
13. Verheijden GF, Rijnders AW, Bos E, Coenen-de Roo CJ, van Staveren CJ, Miltenburg AM, Meijerink JH, Elewaut D, de Keyser F, Veys E, Boots AM: Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997, 40:1115-1125.
14. Steenbakkers PG, Baeten D, Rovers E, Veys EM, Rijnders AW, Meijerink J, De Keyser F, Boots AM: Localization of MHC class II/ human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies. J Immunol 2003, 170:5719-5727.
15. Smith MD, O'Donnell J, Highton J, Palmer DG, Rozenbilds M, Roberts- Thomson PJ: Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: Scarcity of CD5 positive B cells and IL2 receptor bearing T cells. Pathology 1992, 24 19-26.
16. Veale DJ, FitzGerald O: Psoriatic arthritis - pathogenesis and epidemiology. Clin Exp Rheumatol 2002, 20:S27-S33.
17. Yanni G, Whelan A, Feighery C, Bresnihan B: Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994, 53:39-44.
18. Mulherin D, Fitzgerald O, Bresnihan B: Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996, 39:115-124.
19. Pettit AR, ThoTas R: Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis? Immunol Cell Biol 1999, 77:420-427.
20. Zvaifler NJ, Steinman RM, Kaplan G, Lau LL, Rivelis M: Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. J Clin Invest 1985, 76 789-800.
21. Waalen K, Thoen J, Forre O, Hovig T, Teigland J, Natvig JB: Rheumatoid synovial dendritic cells as stimulators in allogeneic and autologous mixed leukocyte reactions - comparison with autologous monocytes as stimulator cells. Scand J Immunol 1986, 23 233-241.
22. Waalen K, Forre O, Pahle J, Natvig JB, Burmester GR: Characteristics of human rheumatoid synovial and normal blood dendritic cells. Retention of class II major histocompatibility complex antigens and accessory function after short-term culture. Scand J Immunol 1987, 26 525-533.
23. Thomas R, Davis LS, Lipsky PE: Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994, 152:2613-2623.
24. Highton J, Kean A, Hessian PA, Thomson J, Rietveld J, Hart DN: Cells expressing dendritic cell markers are present in the rheumatoid nodule J Rheumatol 2000, 27:339-346.
25. Page G, Lebecque S, Miossec P: Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: Correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002, 168:5333-5341.
26. Balanescu A, Radu E, Nat R, Regalia T, Bojinca V, Predescu V, Predeteanu D: Co-stimulatory and adhesion molecules of dendritic cells in rheumatoid arthritis. J Cell Mol Med 2002, 6:415-425.
27. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J: BDCA-2, BDCT-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000, 165:6037-6046.
28. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN: Characterization of human blood dendritic cell subsets. Blood 2002, 100:4512-4520.
29. Arpinati M, Chirumbolo G, Urbini B, Perrone G, Rondelli D, Anasetti C: Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. Transpl Immunol 2003, 11:345-356.
30. O'Doherty U, Peng M, Gezelter S, Swiggard WJ, Betjes M, Bhardwaj N, Steinman RM: Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994, 82:487-493.
31. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999, 5:919-923.
32. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284 1835-1837.
33. Thomas R, Lipsky PE: Presentation of self peptides by dendritic cells: Possible implications for the pathogenesis of rheumatoid arthritis. Arthritis Rheum 1996, 39:183-190.
34. Crow MK, Kunkel HG: Human dendritic cells: major stimulators of the autologous and allogeneic mixed leucocyte reactions. Clin Exp Immunol 1982, 49:338-346.
35. Tsark EC, Wang W, Teng YC, Arkfeld D, Dodge GR, Kovats S: Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages. J Immunol 2002, 169:6625-6633.
36. Verschure PJ, Van Noorden CJ, Dijkstra CD: Macrophages and dendritic cells during the early stages of antigen-induced arthritis in rats: immunohistochemical analysis of cryostat sections of the whole knee joint. Scand J Immunol 1989, 29:371-381.
37. Holmdahl R, Tarkowski A, Jonsson R: Involvement of macrophages and dendritic cells in synovial inflammation of collagen induced arthritis in DBA/1 mice and spontaneous arthritis in MRL/lpr mice. Autoimmunity 1991, 8:271-280.
38. Briere F, Bendriss-Vermare N, Delale T, Burg S, Corbet C, Rissoan MC, Chaperot L, Plumas J, Jacob MC, Trinchieri G, Bates EE: Origin and filiation of human plasmacytoid dendritic cells. Hum Immunol 2002, 63:1081-1093.
39. Mazzoni A, Segal DM: Controlling the Toll road to dendritic cell polarization. J Leukoc Biol 2004, 75:721-730.
40. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, De Baetselier P, Urbain J, Leo O, Moser M: Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996, 184:1413-1424.
41. Palucka AK, Banchereau J, Blanco P, Pascual V: The interplay of dendritic cell subsets in systemic lupus erythematosus. Immunol Cell Biol 2002, 80:484-488.
42. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, et al.: Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001, 31:3026-3037.
43. Liu YJ, Kanzler H, Soumelis V, Gilliet M: Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2001, 2 585-589.
44. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
45. Gladman DD: Psoriatic arthritis. Baillieres Clin Rheumatol 1995, 9:319-329.
46. Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W: Assessment of patients with psoriatic arthritis: A review of currently available measures. Arthritis Rheum 2004, 50:24-35.
47. Firestein GS: Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
48. Cederblad B, Blomberg S, Vallin H, Perers A, Alm GV, Ronnblom L: Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J Autoimmun 1998, 11:465-470.
49. Robak E, Smolewski P, Wozniacka A, Sysa-Jedrzejowska A, Robak T: Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus. Mediators Inflamm 2004, 13 171-180.
50. Gill MA, Blanco P, Arce E, Pascual V, Banchereau J, Palucka AK: Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol 2002, 63:1172-1180.
51. Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J: Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA 2005, 102:3372-3377.
52. Lande R, Giacomini E, Serafini B, Rosicarelli B, Sebastiani GD, Minisola G, Tarantino U, Riccieri V, Valesini G, Coccia EM: Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol 2004, 173:2815-2824.
53. Cavanagh LL, Boyce A, Smith L, Padmanabha J, Filgueira L, Pietschmann P, Thomas R: Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther 2005, 7:R230-R240.
54. Valent P: Immunophenotypic characterization of human basophils and mast cells. Chem Immunol 1995, 61:34-48.
55. Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, Lund-Johansen F: DeAdritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 1997, 94 12551-12556.
56. Korpelainen EI, Gamble JR, Vadas MA, Lopez AF: IL-3 receptor expression, regulation and function in cells of the vasculature. Immunol Cell Biol 1996, 74:1-7.
57. Sun Q, Woodcock JM, Rapoport A, Stomski FC, Korpelainen EI, Bagley CJ, Goodall GJ, Smith WB, Gamble JR, Vadas MA, Lopez AF: Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist. Blood 1996, 87:83-92.
58. Shodell M, Siegal FP: Corticosteroids depress IFN-alpha-producing plasmacytoid dendritic cells in human blood. J Allergy Clin Immunol 2001, 108:446-448.
59. Vanderheyde N, Verhasselt V, Goldman M, Willems F: Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 1999, 67:1342-1347.
60. Van Krinks CH, Matyszak MK, Gaston JS: Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid Rheumatology (Oxford) 2004, 43:453-460.
61. Rosen SD: Ligands Hor L-selectin: homing, inflammation, and beyond Annu Rev Immunol 2004, 22:129-156.
62. Pelletier JP, Martel-Pelletier J, Abramson SB: Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001, 44:1237-1247.
63. Ponchel F, Verburg RJ, Bingham SJ, Brown AK, Moore J, Protheroe A, Short K, Lawson CA, Morgan AW, Quinn M, et al.: Interleukin-7 deficiency in rheumatoid arthritis: Consequences for therapy-induced lymphopenia. Arthritis Res Ther 2005, 7:R80-R92.
64. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA: Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988, 31:1041-1045.
65. Tetta C, Camussi G, Modena V, Di Vittorio C, Baglioni C: Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann Rheum Dis 1990, 49 665-667.
66. Jacobsen SE, Veiby OP, Myklebust J, Okkenhaug C, Lyman SD: Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha. Blood 1996, 87:5016-5026.
67. Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, Yakushijin T, Oki C, Itose I, Hiramatsu N, Takehara T, et al.: Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 2004, 190:1919-1926.
68. Bond A, Hay FC: L-selectin expression on the surface of peripheral blood leucocytes from rheumatoid arthritis patients is linked to disease activity. Scand J Immunol 1997, 46:312-316.
69. Mojcik CF, ShevacA EM: Adhesion molecules: a rheumatologic perspective. Arthritis Rheum 1997, 40:991-1004.
70. Gazitt Y: Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors. Stem Cells 2000, 18:390-398.
71. Gilliet M, Conrad C, Geiges M, Cozzio A, Thurlimann W, Burg G, Nestle FO, Dummer R: Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004, 140:1490-1495.
72. Veale DJ, Ritchlin C, FitzGerald O: Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005, 64(Suppl 2) ii26-ii29.
73. Passos de Souza E, Evangelista Segundo PT, Jose FF, Lemaire D, Santiago M: Rheumatoid arthritis induced by alpha-interferon therapy. Clin Rheumatol 2001, 20:297-299.
74. Nadir F, Fagiuoli S, Wright HI, Nadir A, Hopp E, Gavaler J, Van Thiel DH: Rheumatoid aAthritis: a complication of interferon therapy. J Okla State Med Assoc 1994, 87:228-230.
75. Lombardini F, Taglione E, Riente L, Pasero G: Psoriatic arthritis with spinal involvement in a patient receiving alpha-interferon for chronic hepatitis C. Scand J Rheumatol 1997, 26:58-60.
76. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J: Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543.
77. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995, 182:389-400.